Gene · 79813
NIH grants1,962
NIH grants whose papers are about the gene, through NIH's grant-paper links.
721 to 740 of 1,962
Download this page as JSON| Grant | Title | EHMT1 papers | Newest fiscal year |
|---|---|---|---|
| R01HL141917 | Improving Mitral Compensation In Ischemic Regurgitation | 1 | 2021 |
| R01MH067234 | Effects Of Environmental Challenges On Genetically Modified Interneuronal Subpopulations | 1 | 2021 |
| R01MH111721 | Integrative Genomics of the Corticolimbic Circuit in Major Depressive Disorder | 1 | 2021 |
| R01MH113457 | Targeted inactivation of HIV in CNS reservoirs | 1 | 2021 |
| R01MH113715 | Expanding the accessible genetic architecture of autism by single molecule sequencing | 1 | 2021 |
| R01NS102148 | Functions of parkin in Parkinson’s disease | 1 | 2021 |
| R01NS104015 | Nanopeptide Targeting of HIV-CNS Reservoirs without Reactivation | 1 | 2021 |
| R03OD032622 | Interrogation and Interpretation of Common Fund Data Sets to Identify Novel Ocular Disease Genes | 1 | 2021 |
| R21AG067597 | New Treatment Strategy for Alzheimer’s Disease | 1 | 2021 |
| R21HD098621 | Correction of endocrine disruptor-induced transgenerational epimutations by CRISPR-dCas9 | 1 | 2021 |
| R21NS122398 | Cellular Basis for Genetic Susceptibility to Neurodevelopmental Disorders | 1 | 2021 |
| R21NS125449 | Diurnal Experimental Models to Investigate Neural Mechanisms of Sleep Disturbance in Smith-Magenis Syndrome | 1 | 2021 |
| R25GM055052 | UCLA Maximizing Student Development (MSD) Program | 1 | 2021 |
| R35CA210065 | Molecular pathways and targeted therapies in human leukemia | 1 | 2021 |
| R35GM124693 | PARP-1 Signaling in DNA Damage and Cell Death | 1 | 2021 |
| R35GM124764 | Regulation of chromosome structure and gene expression by architectural proteins | 1 | 2021 |
| R35HL139599 | Controlling Influences of Oxygen Tension and CD26/DPP4 Enzymatic Activity on Regulation of Hematopoietic Stem/Progenitor Cells and Hematopoiesis During Health, Ageing, and Disease | 1 | 2021 |
| R37GM042699 | Biochemistry of Pre-mRNA Splicing | 1 | 2021 |
| R37GM086868 | Structure, Function and Applications of Inteins | 1 | 2021 |
| S10OD030286 | Orbitrap Exploris 480 Basic System | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79813/grants?page=37